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Abstract 
Purpose: Functional neurological disorders (FND) are disabling conditions for which there are few 
empirically-supported treatments. Disturbed sleep appears to be part of the FND context; however, 
the clinical importance of sleep disturbance (extent, characteristics and impact) remains largely 
unknown. We described sleep quality in two samples, and investigated the relationship between 
sleep and FND-related functional impairment.  
Methods: We included a sample recruited online via patient charities (N = 205) and a consecutive 
clinical sample (N = 20). Participants completed validated measures of sleep quality and sleep 
characteristics (e.g. total sleep time, sleep efficiency), mood, and FND-related functional 
impairment.  
Results: Poor sleep was common in both samples (89% in the clinical range), which was 
characterised by low sleep efficiency (M = 65.40%) and low total sleep time (M = 6.05 hours). In 
regression analysis, sleep quality was negatively associated with FND-related functional impairment, 
accounting for 16% of the variance and remaining significant after the introduction of mood 
variables.  
Conclusions: These preliminary analyses suggest that subjective sleep disturbance is common in 
FND. Sleep quality was negatively associated with the functional impairment attributed to FND, 
independent of depression. Therefore, sleep disturbance may be a clinically important feature of 
FND.  
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Functional Neurological Disorders (FND) involve neurological symptoms (e.g. seizures, tremor, limb 
weakness) that are inconsistent with known neurological disease pathologies. There are many 
theoretical explanations for FND
1, 2
, and much debate about etiology
3, 4
; however, many believe FND 
to be largely influenced by underlying psychological factors. FND are prevalent conditions
5
, 
representing up to 30% or a neurologists caseload
5
. They can cause high levels of functional 
impairment, which detrimentally affects quality of life and mood 
6, 7
. Prognosis is variable: some 
become symptom free following diagnosis 
8
; for others symptoms persist 
6, 8
 and proliferate
9
. 
Regarding treatments, depending on symptom type, patients are often referred for psychotherapy 
or physiotherapy. However, empirically-supported treatments for FND are lacking 
10, 11
. Improved 
understanding of the factors that contribute to functional impairment should allow us to develop 
new direct or adjunctive treatments for FND.  
The present research is based on a clinical observation: we noted that people with FND attending a 
neuropsychology clinic often complained of sleep disturbance that reportedly affected functioning. A 
search on the topic revealed a literature limited to debate regarding the occurrence of non-epileptic 
seizures during sleep 
12
, and one small study (N= 8) showing a high proportion of REM sleep in 
people with non-epileptic seizures compared to those with epilepsy 
13
. No investigation of the 
clinical relevance of sleep disturbance, its extent, broader characteristics and impact, was apparent. 
This seemed surprising for several reasons. We know that poor sleep worsens outcomes (e.g. quality 
of life and mood) in chronic diseases 
14
 and neuropsychiatric conditions 
15
. It therefore follows that 
sleep might also contribute to outcomes in FND. This is important because if sleep is a clinically 
relevant factor in FND, then sleep treatments may be worthy of trial. Treatments for sleep 
disturbance, such as cognitive behaviour therapy for insomnia (CBT-i), show efficacy for improving 
sleep and consequently other outcomes, such as mood, quality of life and symptom severity, across 
several neuropsychiatric and chronic disease populations 
16
.  
Therefore, we undertook a study of the clinical relevance of sleep disturbance in FND. We recruited 
two samples: a consecutive sample of neuropsychology clinic attenders and a larger sample 
recruited online via a FND patient charity. We quantified the extent and nature of sleep disturbance, 
then tested the hypothesis that sleep quality is associated with FND-related functional impairment.  
Method 
Participants & procedure 
The online sample was recruited via an online survey (Ethical approval: University of Leeds, Medicine 
and Health University Ethics Panel, application number MREC15-125). This survey was promoted to 
people with FND via two FND patient charity websites (FND Hope & FND Action). A link directed 
participants to online information sheets, consent forms and the questionnaire battery. Participants 
assessed themselves against inclusion (presence of FND as diagnosed by a neurologist) and excl usion 
(learning disability; inability to read English) criteria. The questionnaire battery, comprised validated 
questionnaire measures of sleep, mood and FND-related functional impairment. We also collected 
information on demographics, including medication use. To help ensure that only those with FND 
participated: a) recruitment was solely from FND specific charity websites; b) verification questions 
were included; c) participants registered their e-mail addresses; d) secondary gain was low - there 
were no rewards for participation.  
Routinely collected clinical data from a sample of neuropsychology service users was also included, 
mainly as a means to cross-check data collected from the online sample. This clinical sample 
comprised consecutive clinic attenders of the Clinical Neuropsychology Department at St. James 
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University Hospital, between April and November 2016 (ethical approval: considered an NHS clinical 
audit). All had a diagnosis of FND (made at United Kingdom regional neurosciences centre). As part 
of routine clinical practice these participants completed a mood questionnaire (CORE-10) that 
contains an item assessing the frequency of sleep disturbance. 
Questionnaires 
Sleep 
The Sleep Condition Indicator (SCI) 
17
 measured global sleep quality in the online sample. The SCI 
comprises 8 items regarding, for example, perceived sleep quality, duration of sleep difficulties and 
daytime functioning. Participants respond on a five-point scale with lower scores indicating greater 
difficulties in each area. The SCI is transformed into a score of 0 to 10, with a cut-ŽĨĨŽĨA? 5 indicating 
the presence of probable insomnia disorder 
17
.  
The Pittsburgh Sleep Quality Index (PSQI) 
18
 also assesses perceived sleep quality. From the PSQI we 
selected two sub-components (total sleep time [hrs/mins]; sleep efficiency), reflecting clinically 
important aspects of sleep not measured by the SCI. Sleep efficiency reflects the proportion of time 
in bed spent asleep ([# of hours asleep/ # of hours in bed] x 100). Scores can range from 0-100% with 
higher scores indicating better sleep efficiency.  
Sleep item from the CORE-10 
19
: The CORE-10 is a 10 item measure of mood disturbance that is used 
in routine clinical practice. It includes a sleep item  ? ?/ŚĂǀĞŚĂĚĚŝĨĨŝĐƵůƚǇŐĞƚƚŝŶŐƚŽƐůĞĞƉŽƌƐƚĂǇŝŶŐ
ĂƐůĞĞƉ ? ?, which was used to assess subjective sleep quality in our clinical cohort. Responses to this 
item are made on a four-point scale from 0 ( ?ŶŽƚĂƚĂůů ?) to 4 ( ?DŽƐƚŽƌĂůůƚŚĞƚŝŵĞ ?).  
Functional impairment 
The Work and Social Adjustment Scale (WSAS) 
20
 is a 5-item measure of impairment in activities of 
daily living specifically ascribed to a condition (here FND). Scores range from 0-40, with a higher 
score indicating greater impairment. 
Mood 
The Generalised Anxiety Disorder 7-item Scale (GAD-7) 
21
 is a 7 -item measure of anxiety (Lowe et 
al.,2008). The possible range is 0-21, and higher scores indicate greater anxiety severity.  
The 8-item version of the Patient Health Questionnaire (PHQ-8) 
22
 is a redacted (for online use) 
version of the PHQ-9 (suicidal plans item removed), which retains good psychometric properties. 
Scores can range from 0-24, with higher scores indicating more severe depression. To prevent 
confounds with sleep measurement, we removed the sleep item from this measure 
Analyses 
Statistical analyses were undertaken with the SPSS programme 
23
. Data did not meet the 
assumptions for parametric statistical procedures. Thus, non-parametric tests were used 
throughout: robust regression procedures involving bootstrapping (1000 samples) and group 
comparisons via Mann-Whitney U tests.  
Results 
The clinical sample comprised N = 20; the online sample was larger (N = 205). In both samples a 
range of FND symptoms were described, most commonly non-epileptic attacks, tremor and dystonia 
(Table 1). In line with other cohort studies 
8
, the majority of both samples were female and both 
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samples showed mood disturbance. Considerable proportions of the sample were taking 
antidepressant or pain medication (Table 1).  
Questionnaire measures demonstrated adequate internal consistency (S/ PɲA? ? ? ? ?GAD-7: ɲ = .92; 
WSAS: ɲ = .90; PHQ-8: ɲ = .82), where this could be calculated. Removal of the sleep item from the 
PHQ-8 did not affect internal consistency, which remained at ɲ = .82.  
The extent and nature of sleep disturbance 
Poor sleep was common in the clinical sample, with most at the extreme pole on the CORE sleep 
item (Figure 1). Similarly, in the online sample, 89% were below the SCI cut-off indicating the 
probable presence of clinically-significant sleep disturbance. Average sleep quality (SCI) was very 
poor (M = 3.11, SD = 1.78); much lower (p = <.001, d = 0.65) than a normative online sample (N = 10, 
625; M = 5.07, SD = 2.52)
24
. The average pattern of sleep disturbance reflected both short (M = 6.05 
hrs, SD = 2.39 hrs) and inefficient sleep (M = 65.40%, SD = 20.44%; Table 1).  Of the online sample, 
79.50% reported problematic sleep for over one year, with 34.60% taking sleep medication at least 
once a week (PSQI). 
The relationship between sleep disturbance and functional impairment 
In the online sample, those with an SCI score below the cut-off indicating the probable presence of 
insomnia disorder had significantly worse functional impairment (Z = -3.28, p = .001) compared to 
those above this cut-off (M = 29.02, SD = 10.41; M = 22.41, SD = 9.16). In addition, sleep parameters 
accounted for significant proportions of variance (16%) in functional impairment after controlling for 
demographics (Table 2.) This relationship remained significant (SCI) after the inclusion of anxiety and 
depression (ɴ= -1.23 [-2.04, -.37], t = -2.68, p = .005).  
Discussion 
This study suggests that significant sleep disturbance is a feature of FND, characterised by inefficient 
and short sleep. While the extent of sleep disturbance apparent in our online sample is likely to be 
an over-estimation (self-selection bias), we suggest that this finding remains meaningful because: a) 
when compared to a large (N = 10,625) normative online sample, subject to many of the same biases 
24
, those with FND had significantly worse sleep on average; b) the hi gh frequency and extent of 
sleep disturbance was broadly comparable to the results of the consecutive clinical sample  ? offering 
cross-validation, albeit it with a different measure (CORE-10).  
In addition, commensurate with other conditions 
14, 15
, sleep quality was associated with FND-related 
functional impairment  ? accounting for 16% of the variance. The prevalence and impact of poor 
sleep suggests sleep as a potential treatment target in FND. Multicomponent Cognitive Behavioural 
Therapy for Insomnia (CBT-i) is the first choice for improving chronic poor sleep. It has shown to be 
effective for improving a range of outcomes in many different clinical populations 
16
.  In FND, sleep 
treatments may offer some pragmatic benefits. For example, they may enhance existing FND 
treatments, such as psychotherapy or physiotherapy, and may be applicable to those who do not 
require, or want, existing treatments.  
Although use of antidepressant and pain medication is one possible contributory factor, the exact 
reasons for the impact/extent of sleep disturbance were difficult to ascertain within the utilised 
research design. Nonetheless, the parsimonious explanation that the association between sleep and 
FND-related functional impairment is fully explained by depression was countered by the fact that 
sleep quality predicted proportions of variance even with depression in the analysis. One hypothesis 
for future study is that sleep dysfunction worsens dissociation which consequently worsens FND 
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symptoms. Dissociation is a feature of FND, in particular non-epileptic seizures 
25
. A functional 
imaging study with people experiencing non-epileptic seizures observed that the extent of the 
connectivity between areas differentially implicated in non-epileptic seizures (insula, inferior frontal 
gyrus and precentral sulcus), was significantly associated with scores on a measure of dissociation
25
. 
It is possible that sleep influences such pathways. This notion is supported by empirical studies from 
other populations that have, a) observed sleep dysfunction to influence dissociative states
26, 27
 and; 
b) reported an association between dissociation and the number of reported somatic symptoms
28, 29
. 
Limitations 
The cross-sectional design precluded comment on the direction of influence between variables. One 
sample was recruited online; therefore, although several steps were taken to attenuate this issue, it 
remains possible that some without a gold-standard FND diagnosis participated. While some 
variables were directly calculated by the researchers from participant data (e.g. sleep efficiency), all 
variables included here are subjective. Thus, studies involving direct sleep/behaviour monitoring 
would be of benefit. Finally, we did not assess for sleep disorders beyond insomnia-related 
symptoms (e.g. restless legs syndrome, circadian rhythm sleep disorders).  
Conclusion 
Poor sleep appears common in FND and is associated with FND-related functional impairment, 
independent of mood. Longitudinal and experimental studies are required to confirm and extend 
these findings.  
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Table 1. Description of the included samples. 
  Online sample (% or 
SD) 
Clinical Sample (% 
or SD) 
Symptoms    
Non-epileptic seizures 105/205 (51.2%) 7/20 (35%) 
Tremor 117/205 (57.1%) 4/20 (20%) 
Dystonia 70/205 (34.1%) 6/20 (30%) 
Visual symptoms 86/205 (42.0%) 2/20 (10%) 
Other 80/125 (39%) 4/20 (20%) 
Age 40.42 (10.83) 37.85 (15.96) 
Years diagnosed 3.42 (5.00) - 
% Female 87.8% 70% 
Location    
United Kingdom 156/205 (76.1%) 20/20 (100%) 
North America 35/205 (17.1 %) - 
Mainland Europe 5/205 (2.4%) - 
Australia &New Zealand 9/205 (4.4%) - 
Co-morbidity    
Co-morbid illness (e.g. asthma, diabetes, arthritis) 118/205 (57.6%) - 
Pain 163/205 (79.5%) - 
Fatigue 182/205 (88.8%) - 
Medications   
Anti-depressants (e.g. sertraline, citalopram)  108/205 (52.7%) - 
Pain medication (e.g. paracetamol, tramadol) 65/205 (31.7%) - 
Benzodiazepines (e.g. diazepam, alprazolam) 19/205 (9.3%) - 
Anti-epileptic medication, in those with seizures  
(e.g. gabapentin, pregabalin) 
32/105 (30.5%) - 
Vocation    
Employed 48/205 (23.4%) - 
Unemployed not due to health 2/205 (1.0%) - 
Unemployed due to ill health 121/205 (59.0%) - 
Retired 2/205 (1.0%) - 
Student 12/205 (5.9%) - 
Other 20/205 (9.7%) - 
General functioning and mood    
FND-related Functional impairment (WSAS) 28.31/40 (10.46) - 
Depression (PHQ-8) 15.17/24 (5.89) - 
Anxiety (GAD-7) 
CORE-10 total score 
10.21/21 (6.48) 
- 
- 
21.00/40 (7.02) 
Sleep     
Sleep condition (SCI total) 3.11/10 (1.78) - 
Sleep efficiency (PSQI) 65.40% (20.44) - 
Average total sleep time (per night; PSQI) 
CORE-10 Sleep item 
6.05 hours (2.39) 
- 
- 
2.9/4 (1.25) 
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Table 2. Hierarchical regression analyses: The proportions of variance in FND-related functional 
impairment (WSAS) explained by demographics, sleep and mood. 
Step Variable Ȳ ? ? ?й/ ? ? t P* R2 ȴZ2 ȴ& p 
1 Age  -.02 (-.15, .11) -0.27 .763 .02 .02 1.62 .202 
 Years diagnosed  -.33 (-.72, .04) -1.75 .080     
2 Age .06 (-.06, .18) 0.83 .354 .17 .16 17.23 <.001 
 Years diagnosed -.18 (-.55, .20) -1.03 .308     
 Sleep quality (SCI) -2.50 (-3.34, -1.72) -5.59 .001     
 Sleep efficiency (PSQI) .03 (-.04, ,.11) 0.83 .362     
3 Age .07 (-.06, .19) 0.93 .315 .18 .01 1.52 .220 
 Years diagnosed -.18 (-.54, .20) -1.00 .326     
 Sleep quality (SCI) -2.29 (-3.11, -1.42) -4.81 .001     
 Sleep efficiency (PSQI) .03 (-.04, .11) .0.88 .333     
 Anxiety (GAD-7) .15 (-.10, .41) 1.23 .242     
4. Age .06 (-.05, .18) 0.88 .382 .34 .16 42.95 <.001 
 Years diagnosed -.03 (-.37, .34) -0.18 .869     
 Sleep quality (SCI) -1.23 (-2.04, -.37) -2.68 .005     
 Sleep efficiency (PSQI) -.03 (-0.4, .10) 0.76 .412     
 Anxiety (GAD-7) -.43 (-.70, -.15) -3.05 .001     
 Depression (PHQ-7) 1.26 (.87, 1.67) 6.55 .001     
Method: Enter (*taken from robust regression = 1000 bootstrapped samples) 
SCI= Sleep Condition Indicator; PSQI = Pittsburgh Sleep Quality Inventory; GAD-7 = 7-item General 
Anxiety Disorder questionnaire; PHQ-9 = 9-item Patient Health Questionnaire  
a
Sleep Item removed from the PHQ-8; thus, PHQ-7. 
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Figure 1. The frequency of reported sleep disturbances on the CORE-10 Sleep Item in the clinical 
sample (N = 20). 
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Highlights 
x Sleep dysfunction was common in both online and clinical FND samples.   
x In our online FND sample, sleep dysfunction comprised short and inefficient sleep. 
x Sleep quality was negatively associated with functional impairment.  
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